Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

about

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

Item

http://www.wikidata.org/entity/Q36316636

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Outcomes of special histotypes ...... cohort of the BIG 1-98 trial.

@ast

Outcomes of special histotypes ...... cohort of the BIG 1-98 trial.

@en

type

Item

label

Outcomes of special histotypes ...... cohort of the BIG 1-98 trial.

@ast

Outcomes of special histotypes ...... cohort of the BIG 1-98 trial.

@en

prefLabel

Outcomes of special histotypes ...... cohort of the BIG 1-98 trial.

@ast

Outcomes of special histotypes ...... cohort of the BIG 1-98 trial.

@en

P1476

Outcomes of special histotypes ...... y cohort of the BIG 1-98 trial

@en

P2093

A Giobbie-Hurder

http://www.w3.org/2001/XMLSchema#string

A Goldhirsch

http://www.w3.org/2001/XMLSchema#string

A S Coates

http://www.w3.org/2001/XMLSchema#string

B A Gusterson

http://www.w3.org/2001/XMLSchema#string

B Ejlertsen

http://www.w3.org/2001/XMLSchema#string

B Thürlimann

http://www.w3.org/2001/XMLSchema#string

E Mallon

http://www.w3.org/2001/XMLSchema#string

F Bibeau

http://www.w3.org/2001/XMLSchema#string

G Lelkaitis

http://www.w3.org/2001/XMLSchema#string

G MacGrogan

http://www.w3.org/2001/XMLSchema#string

P2860

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

Tubular carcinoma of the breast: results of a large contemporary series.

Histological and molecular types of breast cancer: is there a unifying taxonomy?

P304

2442-2449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDV391

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Colleoni

Elisabetta Munzone

P577

2015-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26387144

http://www.w3.org/2001/XMLSchema#string

P932

4658543

http://www.w3.org/2001/XMLSchema#string